JAMES RITTENBURG - PERKASIE PA, US ELAINE PEARS - ACOMB, GB RICHARD TIER - CLIFTON MOOR, GB STEPHEN TATTERTON - SOUTHBANK, GB IAN ACWORTH - MELROSE MA, US PAUL GAMACHE - HUDSON NH, US WAYNE MATSON - AYER MA, US
International Classification:
G01N033/543
US Classification:
436/518000
Abstract:
In general, the invention features a method of marking a product for identification in which a marker, composed of an electroactive compound, is added to the product and subsequently measured using an electrochemical detector.
Ian Acworth - Melrose MA, US Paul Gamache - Hudson NH, US Michael Granger - Northborough MA, US
International Classification:
G01N 27/26
US Classification:
205775000, 204400000
Abstract:
A device comprising an electrode constructed and arranged to electrochemically activate an electrochemically inactive analyte is disclosed. Methods and systems that implement the device are also provided.
Biosensor For Measurement Of Species In A Body Fluid
Milind Nagale - Lowell MA, US Paul Gamache - Hudson NH, US Ian Acworth - Melrose MA, US William Scott - Billerica MA, US Eric Zink - Burlington MA, US Mark Bowers - Arlington MA, US Michael Granger - Chandler AZ, US
Assignee:
ESA BIOSCIENCES, INC. - Chelmsford MA
International Classification:
G01N 33/53 C12Q 1/26 C12M 3/00
US Classification:
435007100, 435025000, 435287200
Abstract:
Certain embodiments disclosed herein are directed to devices configured to detect the level of a biomarker in a body fluid. In some examples, the device includes two or more electrodes for electrochemical detection of the biomarker in the body fluid. Methods of using the device are also disclosed.
Process And Composition For Increasing Brain Dopamine Release
Richard J. Wurtman - Boston MA Ian Acworth - Brookline MA Michael Kreutz - Oberhauser, DE Hendrik Lehnert - Mainz, DE
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 3724 A61K 31195
US Classification:
514 18
Abstract:
Compositions useful in the treatment of inadequate neuronal dopamine release, as well as methods of use therefor. The compositions include drugs, such as thyrotropin-releasing hormone, which result in enhanced release of dopamine and tyrosine or a tyrosine precursor.